Lab Hra Pharma Drug Patent Portfolio
Lab Hra Pharma owns 1 orange book drug protected by 8 US patents Given below is the list of Lab Hra Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8426392 | Method for providing emergency contraception | 12 Jun, 2030 | Active |
| US8962603 | Method for post coital contraception in overweight or obese female subjects using ulipristal acetate | 12 Jun, 2030 | Active |
| US8512745 | Ulipristal acetate tablets | 02 Jun, 2030 | Active |
| US10159681 | Method for on-demand contraception | 13 Apr, 2030 | Active |
| US10772897 | Method for on-demand contraception | 13 Apr, 2030 | Active |
| US9283233 | Method for on-demand contraception | 13 Apr, 2030 | Active |
| US8735380 | Ulipristal acetate tablets | 20 Feb, 2029 | Active |
| US9844510 | Ulipristal acetate tablets | 08 Dec, 2028 | Active |
Latest Legal Activities on Lab Hra Pharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Lab Hra Pharma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 27 Feb, 2024 | US10772897 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 05 Sep, 2023 | US9283233 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 07 Jun, 2022 | US10159681 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 09 Nov, 2021 | US8735380 (Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 01 Jun, 2021 | US9844510 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 19 Feb, 2021 | US8512745 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 06 Oct, 2020 | US8426392 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 15 Sep, 2020 | US10772897 |
|
Recordation of Patent Grant Mailed
Critical
| 15 Sep, 2020 | US10772897 |
|
Email Notification
Critical
| 27 Aug, 2020 | US10772897 |
| Printer Rush- No mailing | 26 Aug, 2020 | US10772897 |
|
Issue Notification Mailed
Critical
| 26 Aug, 2020 | US10772897 |
| Mailing Corrected Notice of Allowability | 26 Aug, 2020 | US10772897 |
|
Email Notification
Critical
| 26 Aug, 2020 | US10772897 |
| Corrected Notice of Allowability | 21 Aug, 2020 | US10772897 |
Lab Hra Pharma Drug Patents' Oppositions Filed in EPO
Lab Hra Pharma drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Apr 19, 2017, by Hexal Ag. This opposition was filed on patent number EP09764855A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP10717084A | May, 2017 | Mutlu, Aydin | Revoked |
| EP10717084A | May, 2017 | Generics (U.K.) Limited | Revoked |
| EP10717084A | May, 2017 | EGIS Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Revoked |
| EP10717084A | May, 2017 | Stada-Arzneimittel Aktiengesellschaft | Revoked |
| EP10717084A | May, 2017 | HEXAL PHARMA AG | Revoked |
| EP10717084A | May, 2017 | Helm AG | Revoked |
| EP09764855A | Apr, 2017 | Cyndea Pharma. S.L. | Revoked |
| EP10717084A | Apr, 2017 | Teva Pharmaceutical Industries Ltd. | Revoked |
| EP09764855A | Apr, 2017 | Helm AG | Revoked |
| EP09764855A | Apr, 2017 | Hexal AG | Revoked |
Lab Hra Pharma's Family Patents
Lab Hra Pharma Drug List
Given below is the complete list of Lab Hra Pharma's drugs and the patents protecting them.
1. Ella
Ella is protected by 8 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8426392 | Method for providing emergency contraception |
12 Jun, 2030
(5 years from now)
| Active |
| US8962603 | Method for post coital contraception in overweight or obese female subjects using ulipristal acetate |
12 Jun, 2030
(5 years from now)
| Active |
| US8512745 | Ulipristal acetate tablets |
02 Jun, 2030
(5 years from now)
| Active |
| US10159681 | Method for on-demand contraception |
13 Apr, 2030
(5 years from now)
| Active |
| US10772897 | Method for on-demand contraception |
13 Apr, 2030
(5 years from now)
| Active |
| US9283233 | Method for on-demand contraception |
13 Apr, 2030
(5 years from now)
| Active |
| US8735380 | Ulipristal acetate tablets |
20 Feb, 2029
(4 years from now)
| Active |
| US9844510 | Ulipristal acetate tablets |
08 Dec, 2028
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ella's drug page